Walden Biosciences Alternatives & Competitors
12 companies similar to Walden Biosciences — Transforming the Treatment of Kidney Disease
Companies similar to Walden Biosciences
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
Attralus
Attralus is a biopharmaceutical company creating transformative medicines for patients wit...
Naples, United States
BridgeBio
We move at the speed of patient need.
Palo Alto, United States
Rival Readout
Competing with Walden Biosciences? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Evommune
Developing innovative therapies that target key drivers of chronic inflammatory diseases.
Palo Alto, United States
Ultragenyx
Going Beyond Every Day
Novato, United States
VRise Therapeutics, Inc.
A Precision Oncology Company
Cambridge, United States
VectivBio
Biotech company develops treatments for severe rare diseases, aims to become global leader...
Basel, Switzerland
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
New York, United States
Eikon Therapeutics
Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and develo...
Millbrae, United States
Nitrase Therapeutics
Pioneering Nitrase Biology and Medicines
Brisbane, United States
About Walden Biosciences
Walden Biosciences, founded in 2020 and headquartered in the United States, is a promising player in the Biotechnology, Health Care, and Life Sciences industries. With a slogan of "Transforming the Treatment of Kidney Disease," the company is pioneering the development of first-in-class therapies aimed at halting and r...
Developing novel kidney disease therapies, Advancing clinical pipeline, Phase 2 program development
Patients with kidney disease, Physicians specializing in nephrology, Healthcare providers, Medical researchers
Kidney Disease, Therapies, Drug Discovery, Biological Pathways, Renal Disease, Systems-based Approach, Innovative Medicines, Therapeutic Development, Disease Pathology, Cambridge MA, Transformative Medicines, Patient-centered Approach, Clinical Innovation, Data-driven Decision Making
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Walden Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Walden Biosciences on 20 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
